Outcome of Board Meeting

02.11.2026 National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Floor- 25, P J Tower, Bandra-Kurla Complex, Dalal Street, Bandra (East) Mumbai 400 051 Mumbai 400 001 SYMBOL:- EPIGRAL Scrip Code: 543332 Dear Sirs, Sub.: Outcome of Board Meeting held on Monday, 2nd November, 2026 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year ended 30th September, 2026. Pursuant to Regulations 30, 33 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of Epigral Limited [‘the Company’] at its meeting held today i.e. Monday, 2nd November, 2026 has inter-alia discussed, approved, and taken on record the following matters: 1. Approved Un-Audited Financial Results (Standalone & Consolidated) of the Company for the Second Quarter and Half Year ended on 30th September, 2026; and took on record ‘Limited Review Report’ thereon issued by M/s. S R B C & CO LLP, Statutory Auditors of the Company. A copy of the approved Un-Audited Financial Results along with Limited Review Report are enclosed herewith. The meeting commenced at 12:00 Noon and concluded at 01:40 p.m. at the Registered Office of the Company situated at Ahmedabad. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Epigral Limited Gaurang Trivedi Company Secretary & Compliance Officer M. No. – A22307